Abraxane

No structure available

This product's active ingredient could not be matched to a single known compound.

Registration

Applicants: 1
Registrations: 1

Applicants and registrations

Applicant	Brands	Dosages	Registrations	Schedule	Leaflets
Key Oncologics (Pty) Ltd	Abraxane	100 mg	500182	Not determined	PI PIL

Variants

Product	Strength and form	Registration	Status	Schedule	Leaflets
Abraxane EACH VIAL CONTAINS : ALBUMIN-BOUND PACLITAXEL 100,0 mg	100 mgPowder for suspension for infusion.	50018250/26/0182Approved 24 May 2024	Registered	Not determined	PI PIL

Regulatory status

This product is still scheduled by law even when this site could not determine which tier it falls under. The label carries the S number in a square border; ask a pharmacist if you need to know its schedule.

This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.

Background

Loading Wikipedia summary

SAHPRA documents

Professional information (PI)For healthcare professionalsAbraxane, Key Oncologics (Pty) Ltd Patient information leaflet (PIL)For patients and carersAbraxane, Key Oncologics (Pty) Ltd

These documents come from SAHPRA's PI-PIL repository unless the line under a document says otherwise. Always consult with a healthcare professional for medical advice.

Research articles

Loading PubMed articles